| pubmed-article:10644075 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10644075 | lifeskim:mentions | umls-concept:C0007012 | lld:lifeskim |
| pubmed-article:10644075 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
| pubmed-article:10644075 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:10644075 | lifeskim:mentions | umls-concept:C1512693 | lld:lifeskim |
| pubmed-article:10644075 | lifeskim:mentions | umls-concept:C0209263 | lld:lifeskim |
| pubmed-article:10644075 | lifeskim:mentions | umls-concept:C0205198 | lld:lifeskim |
| pubmed-article:10644075 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:10644075 | pubmed:dateCreated | 2000-2-29 | lld:pubmed |
| pubmed-article:10644075 | pubmed:abstractText | Piroxicam is a poorly soluble NSAID, whose solubility is enhanced when included into beta-cyclodextrin. The preparation of a piroxicam-beta-cyclodextrin inclusion compound using supercritical CO2 was investigated. | lld:pubmed |
| pubmed-article:10644075 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10644075 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10644075 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10644075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10644075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10644075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10644075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10644075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10644075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10644075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10644075 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10644075 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:10644075 | pubmed:issn | 0724-8741 | lld:pubmed |
| pubmed-article:10644075 | pubmed:author | pubmed-author:ThunusLL | lld:pubmed |
| pubmed-article:10644075 | pubmed:author | pubmed-author:DelattreLL | lld:pubmed |
| pubmed-article:10644075 | pubmed:author | pubmed-author:PielGG | lld:pubmed |
| pubmed-article:10644075 | pubmed:author | pubmed-author:OtsuII | lld:pubmed |
| pubmed-article:10644075 | pubmed:author | pubmed-author:EvrardBB | lld:pubmed |
| pubmed-article:10644075 | pubmed:author | pubmed-author:Van HeesTT | lld:pubmed |
| pubmed-article:10644075 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10644075 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:10644075 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10644075 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10644075 | pubmed:pagination | 1864-70 | lld:pubmed |
| pubmed-article:10644075 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:meshHeading | pubmed-meshheading:10644075... | lld:pubmed |
| pubmed-article:10644075 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10644075 | pubmed:articleTitle | Application of supercritical carbon dioxide for the preparation of a piroxicam-beta-cyclodextrin inclusion compound. | lld:pubmed |
| pubmed-article:10644075 | pubmed:affiliation | Department of Pharmaceutical Technology, Institute of Pharmacy, University of Liege, Belgium. | lld:pubmed |
| pubmed-article:10644075 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10644075 | lld:pubmed |
